Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Eliem Therapeutics, Inc. | President and CEO, Director | Restricted Stock Units | 275K | $1.98M | $7.21 | Jun 27, 2024 | Direct |
SYNLOGIC, INC. | President and CEO, Director | Common Stock | 256K | $148K | $0.58 | Apr 3, 2023 | Direct |
FIBROGEN INC | Director | Common Stock | 27.9K | $21.2K | $0.76 | Jun 9, 2023 | Direct |
Eliem Therapeutics, Inc. | President and CEO, Director | Stock Option (Right to Buy) | 550K | Jun 27, 2024 | Direct | ||
FIBROGEN INC | Director | Stock Option (Right to Buy) | 70K | Jun 5, 2024 | Direct | ||
Xilio Therapeutics, Inc. | Director | Stock Option (right to buy) | 50K | Jun 13, 2024 | Direct | ||
SYNLOGIC, INC. | President and CEO, Director | Stock Option (right to buy) | 8.67K | Nov 10, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ELYM | Eliem Therapeutics, Inc. | Jun 27, 2024 | 2 | $0 | 4 | Jun 27, 2024 | President and CEO, Director |
ELYM | Eliem Therapeutics, Inc. | Jun 27, 2024 | 0 | $0 | 3 | Jun 27, 2024 | President and CEO, Director |
XLO | Xilio Therapeutics, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 17, 2024 | Director |
XLO | Xilio Therapeutics, Inc. | Jun 13, 2024 | 0 | $0 | 3 | Jun 17, 2024 | Director |
FGEN | FIBROGEN INC | Jun 5, 2024 | 1 | $0 | 4 | Jun 6, 2024 | Director |
SYBX | SYNLOGIC, INC. | Nov 10, 2023 | 20 | $0 | 4 | Nov 14, 2023 | President and CEO, Director |
FGEN | FIBROGEN INC | Jun 7, 2023 | 4 | -$81.4K | 4 | Jun 9, 2023 | Director |
SYBX | SYNLOGIC, INC. | Apr 3, 2023 | 1 | -$11K | 4 | Apr 5, 2023 | President and Chief Executive Officer, Director |
FGEN | FIBROGEN INC | Jun 16, 2022 | 2 | $0 | 4 | Jun 21, 2022 | Director |
SYBX | SYNLOGIC, INC. | Apr 4, 2022 | 1 | -$21.8K | 4 | Apr 6, 2022 | President and Chief Executive Officer, Director |
SYBX | SYNLOGIC, INC. | Feb 4, 2022 | 2 | $0 | 4 | Feb 8, 2022 | President and Chief Executive Officer, Director |
FGEN | FIBROGEN INC | May 26, 2021 | 2 | $0 | 4 | May 28, 2021 | Director |